期刊文献+

Role of epigenetics in transformation of inflammation into colorectal cancer 被引量:10

Role of epigenetics in transformation of inflammation into colorectal cancer
下载PDF
导出
摘要 Molecular mechanisms associated with inflammation-promoted tumorigenesis have become an important topic in cancer research. Various abnormal epigenetic changes, including DNA methylation, histone modification, chromatin remodeling, and noncoding RNA regulation, occur during the transformation of chronic inflammation into colorectal cancer(CRC). These changes not only accelerate transformation but also lead to cancer progression and metastasis by activating carcinogenic signaling pathways. The NF-κB and STAT3 signaling pathways play a particularly important role in the transformation of inflammation into CRC, and both are critical to cellular signal transduction and constantly activated in cancer by various abnormal changes including epigenetics. The NF-κB and STAT3 signals contribute to the microenvironment for tumorigenesis through secretion of a large number of pro-inflammatory cytokines and their crosstalk in the nucleus makes it even more difficult to treat CRC. Compared with gene mutation that is irreversible, epigenetic inheritance is reversible or can be altered by the intervention. Therefore, understanding the role of epigenetic inheritance in the inflammation-cancer transformation may elucidate the pathogenesis of CRC and promote the development of innovative drugs targeting transformation to prevent and treat this malignancy. This review summarizes the literature on the roles of epigenetic mechanisms in the occurrence and development of inflammation-induced CRC. Exploring the role of epigenetics in the transformation of inflammation into CRC may help stimulate futures studies on the role of molecular therapy in CRC. Molecular mechanisms associated with inflammation-promoted tumorigenesis have become an important topic in cancer research. Various abnormal epigenetic changes, including DNA methylation, histone modification, chromatin remodeling, and noncoding RNA regulation, occur during the transformation of chronic inflammation into colorectal cancer(CRC). These changes not only accelerate transformation but also lead to cancer progression and metastasis by activating carcinogenic signaling pathways. The NF-κB and STAT3 signaling pathways play a particularly important role in the transformation of inflammation into CRC, and both are critical to cellular signal transduction and constantly activated in cancer by various abnormal changes including epigenetics. The NF-κB and STAT3 signals contribute to the microenvironment for tumorigenesis through secretion of a large number of pro-inflammatory cytokines and their crosstalk in the nucleus makes it even more difficult to treat CRC. Compared with gene mutation that is irreversible, epigenetic inheritance is reversible or can be altered by the intervention. Therefore, understanding the role of epigenetic inheritance in the inflammation-cancer transformation may elucidate the pathogenesis of CRC and promote the development of innovative drugs targeting transformation to prevent and treat this malignancy. This review summarizes the literature on the roles of epigenetic mechanisms in the occurrence and development of inflammation-induced CRC. Exploring the role of epigenetics in the transformation of inflammation into CRC may help stimulate futures studies on the role of molecular therapy in CRC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第23期2863-2877,共15页 世界胃肠病学杂志(英文版)
关键词 COLORECTAL cancer INFLAMMATION DNA METHYLATION HISTONE modification LncRNA MicroRNAs EPIGENETICS Colorectal cancer Inflammation DNA methylation Histone modification LncRNA MicroRNAs Epigenetics
  • 相关文献

参考文献1

二级参考文献50

  • 1Adam Low,Melanie Love,Robert Walt,Katherine Kane,Bertus Eksteen,Jason Goh.Understanding of chemoprophylaxis and concordance in inflammatory bowel disease[J].World Journal of Gastroenterology,2010,16(5):578-582. 被引量:2
  • 2Eaden,Abrams,Ekbom,Jackson,Mayberry.Colorectal cancer prevention in ulcerative colitis: a case‐control study[J]. Aliment Pharmacol Ther . 2001 (2)
  • 3Fatima Haggar,Robin Boushey.Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors[J].Clinics in Colon and Rectal Surgery.2009(04)
  • 4Venkataraman Subramanian,Richard F. Logan.Chemoprevention of colorectal cancer in inflammatory bowel disease[J].Best Practice & Research Clinical Gastroenterology.2011(4)
  • 5Laurence Maiden,Bjarni Thjodleifsson,Asgeir Theodors,Juan Gonzalez,Ingvar Bjarnason.A Quantitative Analysis of NSAID-Induced Small Bowel Pathology by Capsule Enteroscopy[J].Gastroenterology.2005(5)
  • 6Lisa L. Strate,Yan L. Liu,Edward S. Huang,Edward L. Giovannucci,Andrew T. Chan.Use of Aspirin or Nonsteroidal Anti-inflammatory Drugs Increases Risk for Diverticulitis and Diverticular Bleeding[J]. Gastroenterology . 2011 (5)
  • 7Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years[J]. Gastroenterology . 2012 (2)
  • 8Matthias Egger,George Davey Smith,Martin Schneider,Christoph Minder.Bias in meta-analysis detected by a simple, graphical test. British Medical Journal . 1997
  • 9Stuart R. Cairns,John H. Scholefield,Robert J. Steele.Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut . 2010
  • 10Bansal P,Sonnenberg A.Risk factors of colorectal cancer in inflammatory bowel disease. The American journal of Gastroenterology . 1996

共引文献5

同被引文献58

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部